Duke Retinal Researchers Identify a Previously Undetected Form of CRB1
Unexpected Findings Could Lead to Future Gene Therapy for Patients Battling Retinal Degeneration
Unrelenting Advocacy
A Parent’s Love and Tenacity Leads to Duke Eye Center, and an Appeal to Innovate
Robotic Optical Coherence Tomography System Demonstrates Potential to Improve Patient Care
Duke has a long history of pioneering Optical Coherence Tomography (OCT) technology that has revolutionized patient care for adults and pediatric patients.&nb
Herndon and Trainees Featured in EyeNet - The Power of Representation in Ophthalmology
Duke Glaucoma Division Chief and Professor of Ophthalmology, Leon W.
Surface Ophthalmics Announces First Patient Dosed in Phase II Trial for SURF-200 for Acute Dry Eye
SURF-200 leverages the proven Klarity vehicle and betamethasone corticosteroid to treat acute dry eye
Duke Ophthalmology Represented During 44th Virtual Annual Macula Society Meeting
We are proud to report that Duke Ophthalmology was well represented during the 44th Virtual Annual Macula Society Meeting held February 6-7, 2021.
Is Vitreoretinal Surgery Safe for Patients with COVID-19?
Retinal surgeon offers clinical considerations when preparing to operate
As the COVID-19 pandemic continues to pose challenges i
Tackling Social Injustice & Health Disparities
American Glaucoma Society Secretary, Duke Glaucoma Division Chief and Professor of Ophthalmology, Leon W.